Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Allogeneic and autologous transplantation for chronic lymphocytic leukemia

Leukemia volume 15, pages 1317–1325 (2001)Cite this article

Abstract

Autologous and allogeneic transplantation are increasingly used in the management of patients with chronic lymphocytic leukemia. Many questions regarding patient selection, efficacy and outcome are unresolved, hence a review of the literature through Medline search. Autologous transplantation for CLL has been used mainly in selected patients under the age of 60. Conditioning typically involves total body irradiation (TBI). Bone marrow and more recently peripheral blood stem cells are used. Treatment-related mortality in most series is less than 10%. Molecular remissions after autologous transplantation are common, and clinical remissions can be prolonged in some patients. Randomized studies are needed to establish whether autologous transplantation confers a survival benefit over standard chemotherapy approaches. Allogeneic transplantation has a considerable treatment-related mortality, but durable remissions sometimes occur in patients with advanced disease. The use of non-myeloablative ‘mini-transplants’ has been investigated as a method to reduce treatment-related mortality, but prolonged follow-up will be required to establish the cure rate obtained with this procedure. Autologous and allogeneic transplantation are promising treatment modalities. Further refinements of transplant techniques and properly designed prospective studies are necessary to establish the role of stem cell transplantation in the overall management of CLL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kalil N, Cheson B . Chronic lymphocytic leukemia Oncologist 1999 4: 352–369

    CAS  PubMed  Google Scholar 

  2. Kipps TJ . Chronic lymphocytic leukemia Curr Opin Hematol 1998 5: 244–253

    Article  CAS  Google Scholar 

  3. de Lima M, O'Brien S, Lerner S, Keating MJ . Chronic lymphocytic leukemia in the young patient Semin Oncol 1998 25: 107–116

    CAS  PubMed  Google Scholar 

  4. Frei E III, Holden SA, Gonin R, Waxman DJ, Teicher BA . Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies Cancer Chemother Pharmacol 1993 33: 113–122

    Article  Google Scholar 

  5. Frei E III, Canellos GP . Dose: a critical factor in cancer chemotherapy Am J Med 1980 69: 585–594

    Article  Google Scholar 

  6. Gale RP, Montserrat E . Intensive therapy of chronic lymphocytic leukaemia Baillières Clin Haematol 1993 6: 879–885

    Article  CAS  Google Scholar 

  7. Rabinowe SN, Soiffer RJ, Gribben JG, Daley H, Freedman AS, Daley J, Pesek K, Neuberg D, Pinkus G, Leavitt PR, Spector NA, Grossbard ML, Anderson K, Robertson MJ, Mauch P, Chayt-Marcus K, Ritz J, Nadler LM . Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia Blood 1993 82: 1366–1376

    CAS  PubMed  Google Scholar 

  8. Gribben JG, Neuberg D, Soiffer RJ, Fisher DC, Schlossman R, Alyea EP, Kuhlman C, Ritz J, Nadler LM . Autologous versus allogeneic bone marrow transplantation for patients with poor prognosis CLL Blood 1998 92: (Suppl. 1) (Abstr. 1320)

    Google Scholar 

  9. Khouri IF, Keating MJ, Vriesendorp HM, Reading CL, Przepiorka D, Huh YO, Andersson B, Van Besien KW, Mehra RC, Giralt SA, Ippoliti C, Marshall M, Thomas MW, O'Brien S, Robertson LE, Deisseroth AB, Champlin RE . Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia J Clin Oncol 1994 12: 748–758

    Article  CAS  Google Scholar 

  10. Khouri I, Thomas M, Marshall M, Reading C, Andersson B, Przepiorka D, Champlin R . B-cell depletion using immunomagnetic beads for autologous bone marrow transplantation in chronic lymphocytic leukemia Exp Hematol 1992 20: 707 (Abstr.)

    Google Scholar 

  11. Esteve J, Villamor N, Colomer D, Bosch F, Lopez-Guillermo A, Rovira M, Urbano-Ispizua A, Sierra J, Carreras E, Montserrat E . Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution Ann Oncol 1998 9: 167–172

    Article  CAS  Google Scholar 

  12. Pavletic ZS, Bierman PJ, Vose JM, Bishop MR, Wu CD, Pierson JL, Kollath JP, Weisenburger DD, Kessinger A, Armitage JO . High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma Ann Oncol 1998 9: 1023–1026

    Article  CAS  Google Scholar 

  13. Montserrat E, Esteve J, Schmitz N, Dreger P, Meloni G, Catovsky D, Dearden C, Scime R, Sutton L, Kimby E, Desablens B, Pavletic S, Coiffier B, Juliusson G, Besalduch J, Del Potro E, Caballero D, Michallet M . Autologous stem-cell transplantation (ASCT) for chronic lymphocytic leukemia (CLL): Results in 107 patients Blood 1999 94: (Suppl. 1) (Abstr. 1758)

    Google Scholar 

  14. Horowitz MM, Montserrat E, Sobocinski K, Giralt S, Khouri IF, Schmitz N . Hematopoietic stem cell transplantation (sct) for chronic lymphocytic leukemia (CLL) Blood 2000 96: (Suppl. 1) (Abstr. 2245)

    Google Scholar 

  15. Dreger P, van Biezen A, Brand R, Esteve J, Gratwohl A, Kimby E, Michallet M, Milligan DW . Prognostic factors for survival after autologous stem cell transplantation for chronic lymphocytic leukemia (CLL): the EBMT experience Blood 2000 96: (Suppl. 1) (Abstr. 2071)

    Google Scholar 

  16. Forsyth PD, Milligan DW, Davies FE, Morgan GJ, Child JA, Cunningham D, Catovsky D . High-dose chemoradiotherapy with autologous stem cell rescue for patients with CLL is an effective and safe means of inducing molecular responses: an MRC pilot study Blood 2000 96: (Suppl. 1) (Abstr. 3642)

    Google Scholar 

  17. Scime R, Santoro A, Tringali S, Musso M, Olivieri A, Narni F, Iacopino P, Donelli A, Mariani G, Leoni P, Majolino I . A multicenter study of autologous PBSC transplantation in chronic lymphocytic leukemia Blood 1999 94: (Suppl. 1) (Abstr. 5041)

    Google Scholar 

  18. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF . Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML Blood 1994 83: 3068–3076

    CAS  PubMed  Google Scholar 

  19. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN . Gene-marking to trace origin of relapse after autologous bone-marrow transplantation Lancet 1993 341: 85–86

    Article  CAS  Google Scholar 

  20. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM . Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma N Engl J Med 1991 325: 1525–1533

    Article  CAS  Google Scholar 

  21. Andersen N, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS, Gribben JG . Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease Blood 1997 90: 4212–4221

    CAS  PubMed  Google Scholar 

  22. Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P, Soiffer R, Ritz J, Nadler LM, Gribben JG . Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation Blood 1996 88: 2228–2235

    CAS  PubMed  Google Scholar 

  23. Dreger P, von Neuhoff N, Kuse R, Sonnen R, Glass B, Uharek L, Schoch R, Loffler H, Schmitz N . Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure? Br J Cancer 1998 77: 2291–2297

    Article  CAS  Google Scholar 

  24. Estrov Z, Zipf T, O'Brien S, Harris D, Ouspenskaia MV, Van Q, Robertson LE, Kantarjian H, Deisseroth AB, Talpaz M, Keating M . Identification of chronic lymphocytic leukemia progenitor cells Blood 1994 84: (Suppl. 1) 458a (Abstr.)

    Google Scholar 

  25. Gahn B, Wendenburg B, Troff C, Neef J, Grove D, Haferlach T, Hiddemann W, Wormann B . Analysis of progenitor cell involvement in B-CLL by simultaneous immunophenotypic and genotypic analysis at the single cell level Br J Haematol 1999 105: 955–959

    Article  CAS  Google Scholar 

  26. Gahn B, Schafer C, Neef J, Troff C, Feuring-Buske M, Hiddemann W, Wormann B . Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia Blood 1997 89: 4275–4281

    CAS  PubMed  Google Scholar 

  27. Paulus U, Schmitz N, Viehmann K, von Neuhoff N, Dreger P . Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL Bone Marrow Transplant 1997 20: 415–420

    Article  CAS  Google Scholar 

  28. Dreger P, Viehmann K, von Neuhoff N, Jopp P, Mitsky P, Mills B, Schmitz N . A prospective study of positive/negative isolex purging of PBSC grafts from patients with chronic lymphocytic leukemia (CLL) Blood 1999 94: (Suppl. 1) (Abstr. 2831)

    Google Scholar 

  29. Magni M, Di Nicola M, Devizzi L, Matteucci P, Lombardi F, Gandola L, Ravagnani F, Giardini R, Dastoli G, Tarella C, Pileri A, Bonadonna G, Gianni AM . Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion Blood 2000 96: 864–869

    CAS  PubMed  Google Scholar 

  30. O'Brien SM, Kantarjian HM, Cortes J, Beran M, Koller CA, Giles FJ, Lerner S, Keating M . Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia J Clin Oncol 2001 19: 1414–1420

    Article  CAS  Google Scholar 

  31. Flinn IW, Byrd JC, Morrison C, Jamison J, Diehl LF, Murphy T, Piantadosi S, Seifter E, Ambinder RF, Vogelsang G, Grever MR . Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies Blood 2000 96: 71–75

    CAS  PubMed  Google Scholar 

  32. Rai K, Mercier RJ, Cooper R, Freter CB, Brettman L, Santabárbara P . Campath-1H is an effective salvage therapy for fludarabine failing CLL patients. Results of a phase II trial Blood 2000 96: (Suppl. 1) 703 (Abstr.)

    Google Scholar 

  33. Kennedy B, Rawstron AC, Evans P, English A, Haynes AP, Russell NH, Byrne J, Hale G, Morgan GJ, Hillmen P . Campath-1H therapy in 29 patients with refractory CLL: ‘true’ complete remission is an attainable goal Blood 1999 94: (Suppl. 1) (Abstr. 2683)

    Google Scholar 

  34. Keating MJ, O'Brien S, Lerner S, Giles F, Andreeff M, Cortes J, Albitar M, Kantarjian H . Combination chemo-antibody therapy with fludarabine, cyclophosphamide and rituximab achieves high CR rate in previously untreated chronic lymphocytic leukemia Blood 2000 96: (Suppl. 1) 2214 (Abstr.)

    Google Scholar 

  35. Kennedy B, Rawstron AC, Carter C, Ryan M, Speed K, Hillmen P . Campath-1H with fludarabine: a novel highly active combination in refractory CLL Blood 2000 96: (Suppl. 1) 4991 (Abstr.)

    Google Scholar 

  36. Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, Horwitz L . High-dose chemoradiotherapy and autologous marrow transplantation for resistant multiple myeloma Blood 1987 70: 869–872

    CAS  PubMed  Google Scholar 

  37. Donovan JW, Zuckerman A, Stephans K, Gribben JG . Quantitative analysis of residual disease levels by Taqman PCR following bone marrow transplantation in chronic lymphocytic leukemia Blood 2000 96: (Suppl. 1) (Abstr. 3085)

    Google Scholar 

  38. Dreger P, Schmitz N . The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia Leukemia 1997 11: (Suppl. 2) S42-S45

    Google Scholar 

  39. Dreger P, von Neuhoff N, Sonnen R, Kuse R, Seyfarth B, Lorenz G, Glass B, Schmitz N . Efficacy and prognostic implications of early autologous stem cell transplantation for poor-risk chronic lymphocytic leukemia (CLL) Blood 2000 96: (Suppl. 1) (Abstr. 2076)

    Google Scholar 

  40. Sutton L, Maloum K, Gonzalez H, Zouabi H, Azar N, Boccaccio C, Charlotte F, Cosset JM, Gabarre J, Leblond V, Merle-Beral H, Binet JL . Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia Leukemia 1998 12: 1699–1707

    Article  CAS  Google Scholar 

  41. Ittala M, Pelliniemi TT, Rajamaki A, Remes K . Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield Bone Marrow Transplant 1997 19: 647–651

    Article  Google Scholar 

  42. Tricot G, Jagannath S, Vesole D, Nealson J, Tindle S, Langdon M, Cheson B, Crowley J, Barlogie B . Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients Blood 1995 85: 588–596

    CAS  PubMed  Google Scholar 

  43. Sala R, Mauro FR, Bellucci R, De Propris MS, Cordone I, Lisci A, Foa R, De Fabritiis P . Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy Eur J Haematol 1998 61: 14–20

    Article  CAS  Google Scholar 

  44. Michallet M, Thiebaut A, Dreger P, Remes K, Milpied N, Santini G, Hamon M, Bjorkstrand B, Kimby E, Belhabri A, Tanguy ML, Apperley JF . Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP) Br J Haematol 2000 108: 595–601

    Article  CAS  Google Scholar 

  45. Ketterer N, Salles G, Moullet I, Dumontet C, ElJaafari-Corbin A, Tremisi P, Thieblemont C, Durand B, Neidhardt-Berard EM, Samaha H, Rigal D, Coiffier B . Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies Br J Haematol 1998 103: 235–242

    Article  CAS  Google Scholar 

  46. Visani G, Lemoli RM, Tosi P, Martinelli G, Testoni N, Ricci P, Piccaluga PP, Pastano R, Leopardi G, Dizdari A, Motta MR, Rizzi S, Tura S . Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients Br J Haematol 1999 105: 775–779

    Article  CAS  Google Scholar 

  47. Dreger P, Michallet M, Schmitz N . Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective Ann Oncol 2000 11: (Suppl. 1) 49–53

    Article  Google Scholar 

  48. Wendtner CM, Schmitt B, Wilhelm M, Dreger P, Montserrat E, Emmerich B, Hallek M . Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapy Ann Oncol 1999 10: 505–509

    Article  CAS  Google Scholar 

  49. GIMEMA . Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia. A phase III, randomized, multicenter study Hematol Cell Ther 1999 41: 117–125

    Google Scholar 

  50. Waselenko JK, Flynn JM, Byrd JC . Stem-cell transplantation in chronic lymphocytic leukemia: the time for designing randomized studies has arrived Semin Oncol 1999 26: 48–61

    CAS  PubMed  Google Scholar 

  51. deMagalhaes-Silverman M, Donnenberg A, Hammert L, Lister J, Myers D, Simpson J, Ball E . Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia Bone Marrow Transplant 1997 20: 175–177

    Article  CAS  Google Scholar 

  52. Mehta J, Powles R, Singhal S, Iveson T, Treleaven J, Catovsky D . Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia Bone Marrow Transplant 1996 17: 371–375

    CAS  PubMed  Google Scholar 

  53. Jarque I, Palau J, Sanz GF, Guinot M, Gomis F, Martín G, Martínez J, Sanz MA . Delayed complete response after allogeneic bone marrow transplantation in chronic lymphocytic leukemia Blood 1993 82: 1036–1038

    CAS  PubMed  Google Scholar 

  54. Rondon G, Giralt S, Huh Y, Khouri I, Andersson B, Andreeff M, Champlin R . Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia Bone Marrow Transplant 1996 18: 669–672

    CAS  PubMed  Google Scholar 

  55. Khouri I, Keating M, Korbling M, Przepiorka D, Anderlini P, O'Brien S, Giralt S, Ippoliti C, von Wolff B, Gajewski J, Donato M, Claxton D, Ueno N, Andersson B, Gee A, Champlin R . Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 1998 16: 2817–2824

    Article  CAS  Google Scholar 

  56. Sadoun A, Patri S, Delwail V, Chomel JC, Cogne M, Brizard A, Kitzis A, Guilhot F . Molecular remission after allogeneic bone marrow transplantation for chronic lymphocytic leukemia Bone Marrow Transplant 1994 13: 217–219

    CAS  PubMed  Google Scholar 

  57. Mehta J, Powles R, Singhal S, Matthey F, Hamblin M, Middleton G, Prendiville J, Glynne P, Zomas A, Treleaven J, Catovsky D . T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure Bone Marrow Transplant 1996 17: 881–883

    CAS  PubMed  Google Scholar 

  58. Scime R, Tringali S, Santoro A, Cavallaro AM, Majolino I . Delayed complete hematologic and molecular response in refractory B-CLL after allogeneic PBSC transplantation Blood 1999 94: (Suppl. 1) (Abstr. 4930)

    Google Scholar 

  59. Schetelig J, Held TK, Bornhauser M, Thiede C, Ehninger G, Willenbacher W, Kiehl M, Fauser A, Schwerdtfeger R, Kroger N, Zander A, Beyer J, Neubauer A, Huhn D, Hamatologie WS . Nonmyeloablative allogeneic stem cell transplantation in chronic lymphocytic leukemia from related and unrelated donors Blood 2000 96: (Suppl. 1) (Abstr. 857)

    Google Scholar 

  60. Doney KC, The Seattle Bone Marrow Transplant Team . Treatment of chronic lymphocytic leukemia with related donor hematopoietic stem cell transplantation Blood 2000 96: (Suppl. 1) 860 (Abstr.)

    Google Scholar 

  61. Zelenetz AD, Holman P, Duun K, Kunkel LA . Rituximab + donor lymphocyte infusions for relapsed B-cell malignancies post allogeneic transplant Blood 1999 94: (Suppl. 1) (Abstr. 4931)

    Google Scholar 

  62. Michallet M, Archimbaud E, Bandini G, Rowlings PA, Deeg HJ, Gahrton G, Montserrat E, Rozman C, Gratwohl A, Gale RP . HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry Ann Intern Med 1996 124: 311–315

    Article  CAS  Google Scholar 

  63. Gribben JG, Neuberg D, Soiffer R, Fisher DC, Schlossman R, Alyea EP, Kuhlman C, Ritz J, Nadler LM . Autologous versus allogeneic bone marrow transplantation for patients with poor prognosis CLL Blood 1998 92: (Suppl. 1) (Abstr. 1320)

    Google Scholar 

  64. Pavletic ZS, Arrowsmith ER, Bierman PJ, Goodman SA, Vose JM, Tarantolo SR, Stein RS, Bociek G, Greer JP, Wu CD, Kollath JP, Weisenburger DD, Kessinger A, Wolff SN, Armitage JO, Bishop MR . Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia Bone Marrow Transplant 2000 25: 717–722

    Article  CAS  Google Scholar 

  65. Martinez C, Martino R, Brunet S, Sureda A, Nomdedeu J, Garcia A, Soler J, Domingo-Albos A . Allogeneic stem cell transplantation for advanced low-grade lymphoproliferative disorders: report of six cases Haematologica 1996 81: 330–334

    CAS  PubMed  Google Scholar 

  66. Toze Cl, Shepherd JD, Connors JM, Voss NJ, Gascoyne RD, Hogge DE, Klingemann HG, Nantel SH, Nevill TJ, Phillips GL, Reece DE, Sutherland HJ, Barnett MJ . Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia Bone Marrow Transplant 2000 25: 605–612

    Article  CAS  Google Scholar 

  67. Michallet M, Brand R, Dreger P, Millighan D, Esteve J, Kimby E, Apperley J, van Biezen A, Niederweiser D . Allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL): results and prognostic factors for survival after transplantation. Analysis from EBMT registry Blood 2000 96: (Suppl. 1) 875 (Abstr.)

    Google Scholar 

  68. Khouri IF, Przepiorka D, van Besien K, O'Brien S, Mehra R, Vriesendorp H, Andersson B, Giralt S, Korbling M, Keating M, Champlin RE . Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease Br J Haematol 1997 97: 466–473

    Article  CAS  Google Scholar 

  69. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG . Prevention of graft versus host disease by inactivation of host antigen-presenting cells Science 1999 285: 412–415

    Article  CAS  Google Scholar 

  70. Khouri I, Munsell M, Yajzi S, O'Brien S, Giralt S, Korbling M, Ippoliti C, Donato M, Keating M, Champlin R . Comparable survival for nonablative and ablative allogeneic transplantation for chronic lymphocytic leukemia Blood 2000 96: (Suppl. 1) 877 (Abstr.)

    Google Scholar 

  71. Sandmaier BM, Maloney DG, Hegenbart U, McSweeney EN, Shizuru JA, Sahebi F, Chauncey T, Radich J, Maris M, Molina A, Blume K, Forman S, Niederweiser D, Storb R . Non myeloablative conditioning for HLA-identical related allografts for hematologic malignancies Blood 2000 96: (Suppl. 1) 2062 (Abstr.)

    Google Scholar 

  72. Berkahn LC, Simpson DR, Raptis A, Klingemann H-G . Fludarabine/cyclophosphamide/rituxan is an effective regimen for non-myeloablative allogeneic stem cell transplantation (sct) for lymphoid malignancies Blood 2000 96: (Suppl. 1) (Abstr. 799)

    Google Scholar 

  73. Siegel DS, Desikan KR, Mehta J, Singhal S, Fassas A, Munshi N, Anaissie E, Naucke S, Ayers D, Spoon D, Vesole D, Tricot G, Barlogie B . Age is not a prognostic variable with autotransplants for multiple myeloma Blood 1999 93: 51–54

    CAS  PubMed  Google Scholar 

  74. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P . Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 2000 343: 1910–1916

    Article  CAS  Google Scholar 

  75. Zwiebel JA, Cheson BD . Chronic lymphocytic leukemia: staging and prognostic factors Semin Oncol 1998 25: 42–59

    CAS  PubMed  Google Scholar 

  76. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia (see comments) Blood 1999 94: 1840–1847

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Illinois at Chicago, Chicago, IL, USA

    K van Besien, B Keralavarma, S Devine & W Stock

Authors
  1. K van Besien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Keralavarma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Devine
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W Stock
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Besien, K., Keralavarma, B., Devine, S. et al. Allogeneic and autologous transplantation for chronic lymphocytic leukemia. Leukemia 15, 1317–1325 (2001). https://doi.org/10.1038/sj.leu.2402178

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402178

Keywords

This article is cited by

Search

Advanced search

Quick links